Sign Up to like & get
recommendations!
0
Published in 2017 at "Movement Disorders"
DOI: 10.1002/mds.27090
Abstract: Parkinson's disease biomarkers are needed to increase diagnostic accuracy, to objectively monitor disease progression and to assess therapeutic efficacy as well as target engagement when evaluating novel drug and therapeutic strategies. This article summarizes perianalytical…
read more here.
Keywords:
synuclein;
perianalytical considerations;
biomarker studies;
biomarker ... See more keywords